How can we enhance the performance of liver stiffness measurement using fibroscan in diagnosing liver cirrhosis in patients with chronic hepatitis B?

Journal of Clinical Gastroenterology

Volumn 44, Issue 1, 2010, Pages 66-71

  Kim, Seung Up ^a   Kim, Do Young ^a   Park, Jun Yong ^a   Lee, Jin Ha ^a   Ahn, Sang Hoon ^a   Kim, Ja Kyung ^a   Paik, Yong Han ^a   Lee, Kwan Sik ^a   Chon, Chae Yoon ^a   Choi, Eun Hee ^b   Song, Ki Jun ^b   Park, Young Nyun ^c   Han, Kwang Hyub ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Brain Korea 21 Project for Medical Science   (South Korea)

Author keywords

Aminotransferase; Chronic hepatitis B; Cirrhosis; Liver stiffness measurement; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELASTOGRAPHY; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SPLEEN;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ORGAN SIZE; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPLEEN;

EID: 75149148751     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181a95c7f     Document Type: Article

References (24)

1. Craxi A, Antonucci G, Camma C. Treatment options in HBV. J Hepatol. 2006;44:S77-S83.
2. Liaw YF, Sung JJ, Chow WC, et al; Cirrhosis Asian Lamivudine Multicentre Study Group. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521-1531.
3. Bravo AA, Sheth SG, Chopra S; Liver biopsy. N Engl J Med. 2001;344:495-500.
4. Fraquelli M, Sarno A, Girelli C, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968-973.
5. Ganne-Carrié N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006;44: 1511-1517.
6. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713.
7. Foucher J, Castéra L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411-412.
8. Kettaneh A, Marcellin P, Douvin C, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol. 2007;46:628-634.
9. Abergel A, Bonny C, Randl K, et al. Fibroscans measures according to intercostal space: validity and concordance. J Hepatol. 2008;48:S268.
10. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2007;47:380-384.
11. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14:360-369.
12. Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592-595.
13. Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-350.
14. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol. 1995;19: 1409-1417.
15. Dittrich M, Milde S, Dinkel E, et al. Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol. 1983;13: 206-211.
16. Kim BK, Kim SA, Park YN, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver int. 2007;27:969-976.
17. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase- based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2008 [Epub ahead of print].
18. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539.
19. Ogawa E, Furusyo N, Toyoda K, et al. Transient elastography for patients with chronic hepatitis B and C virus infection: noninvasive, quantitative assessment of liver fibrosis. Hepatol Res. 2007;37:1002-1010.
20. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
21. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82: 1046-1051.
22. Castera L, Foucher J, Bertet J, et al. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology. 2006;43:373-374.
23. Colletta C, Smirne C, Fabris C, et al. Value of two non-invasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology. 2005;42:838-845.
24. Poynard T, Halfon P, Castera L, et al; FibroPaca Group. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem. 2007;53:1615-1622.